3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Spondylarthritis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Burkitt Lymphoma
1
Arthritis, Rheumatoid
1
Interventions
Methotrexate
4
Abatacept
3
tocilizumab
2
olokizumab
2
Rituximab
2
tofacitinib
1
secukinumab
1
golimumab
1
baricitinib
1
Radioimmunodetection
1
RC-18
1
Etanercept
1
Double-Blind Method
1
Certolizumab Pegol
1
Antirheumatic Agents
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Arthritis, Rheumatoid
×
Radioimmunodetection
×
Clear all
NCT01590966
2019-08-26
SCINTRA
University Hospital, Ghent
Phase 3
Completed
41 enrolled